Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-09-29

Clinical Trial Update: Dexmedetomidine and Intelligence Development in Pediatric Patients Undergoing Craniotomy [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluated dexmedetomidine and cognitive development in children undergoing craniotomy for brain tumors; the study is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dexmedetomidine (Dexmedetomidine)

Snippet

Sponsor: Peking University First Hospital | Conditions: Brain Neoplasms | Phase 4 | Status: COMPLETED